Glasheen James Walter
Insider CIK 1532830 · RVNC Director · CAPN Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SLNO SOLENO THERAPEUTICS INC | A Award deriv | 2018-06-11 | 2018-06-18 | 15,931 | — | $0 | 15,931 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award | 2018-02-05 | 2018-02-07 | 3,962 | $1.73 | $6.9K | 1,419,489 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award | 2017-10-02 | 2017-10-04 | 13,154 | $0.52 | $6.8K | 26,945 | SEC↗ |
| SLNO SOLENO THERAPEUTICS INC | A Award | 2017-07-06 | 2017-07-17 | 11,213 | $0.61 | $6.8K | 13,791 | SEC↗ |
| CAPN Capnia, Inc. | A Award deriv | 2017-05-08 | 2017-05-09 | 45,139 | — | $0 | 45,139 | SEC↗ |
| CAPN Capnia, Inc. | A Award | 2017-04-07 | 2017-04-13 | 2,578 | $0.63 | $1.6K | 2,578 | SEC↗ |
| CAPN Capnia, Inc. | A Award deriv | 2017-03-07 | 2017-03-10 | 20,000 | — | $0 | 20,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2016-05-05 | 2016-05-09 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2015-05-07 | 2015-05-14 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | A Award deriv | 2014-04-08 | 2014-04-10 | 8,000 | — | $0 | 8,000 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 89,186 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 303,563 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 2,801 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 74,665 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 34,427 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | X Exercise deriv | 2014-02-11 | 2014-02-11 | 149 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | X Exercise deriv | 2014-02-11 | 2014-02-11 | 52,087 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 5,231 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 81,959 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 4,125 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 73,275 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion deriv | 2014-02-11 | 2014-02-11 | 4,546 | — | $0 | 0 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | X Exercise | 2014-02-11 | 2014-02-11 | 149 | — | $0 | 16,852 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion | 2014-02-11 | 2014-02-11 | 16,703 | — | $0 | 16,703 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion | 2014-02-11 | 2014-02-11 | 34,427 | — | $0 | 657,075 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | C Conversion | 2014-02-11 | 2014-02-11 | 622,648 | — | $0 | 622,648 | SEC↗ |
| RVNC Revance Therapeutics, Inc. | X Exercise | 2014-02-11 | 2014-02-11 | 52,087 | — | $0 | 709,162 | SEC↗ |